Scholars Central

Conference abstractPublished 19 Nov 2012

Cancer suicide gene therapy: Apoptosis of the ovarian cancer cells induced by EGFRvIII targeted delivery and cell nucleus targeted expression of the DNA-ase transgenes

Authors: Marek Malecki

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Malignant ovarian cancers are the most deadly of all diseases of the reproductive system. Radical oopherectomy in advanced cancer leads to complete infertility. Fertility sparing surgery followed by systemic therapies may result in infertility of the patients and/or the genetic mutations in oocytes potentially leading to genetic disorders of the offspring. The specific aim of this work was to refine our cancer suicide gene therapy, so the apoptosis is sharply restricted to the ovarian cancer cells only. To attain this aim, we genetically engineered single chain variable fragments targeting EGFRvIII receptors, which are present on the cancer cells only. We also engineered the DNAase having the optimum for it activity at the cell nucleus environment, while having it expressed under the ovary specific promoters. We tested the specificity of delivery with the in situ PCR, immunoPCR, FCM, and NMR. We validated induction of apoptosis with the FCM, qPCR, EELS and EDXS. Upon delivery to the mixed cell cultures spiked with the human ovarian cancers, the cell spheroids, and xenografts in nude mice, the transgenes were very selectively delivered only to the cells expressing EGFRvIII. Moreover, the transgenes were effectively expressed in the targeted ovarian cancer cells. The suicide transgenes induced effective degradation of the genomic DNA within the human ovarian cancer cells only. We demonstrated that the cancer suicide gene therapy through targeted expression of recombinant DNAase is very specific in eliminating cancer cells, while leaving the healthy cells unharmed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Genetic Syndromes & Gene Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Genetic Syndromes & Gene Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Marek Malecki”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels